• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-29a 修饰的脂肪间充质干细胞来源的外泌体通过抑制 TGF-β2/Smad3 信号通路减少过度瘢痕形成。

Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.

机构信息

Department of Plastic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

出版信息

Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12398. Epub 2021 Sep 3.

DOI:10.3892/mmr.2021.12398
PMID:34476508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8436211/
Abstract

Pathological scars mainly refer to hypertrophic scars and keloids, and have a high incidence. Moreover, these scars seriously affect the patient's appearance and are associated with significant pain. The present study aimed to investigate the inhibitory effect of microRNA (miR)‑29a from human adipose‑derived mesenchymal stem cells (hADSCs) exosomes on scar formation. Firstly, the expression of miR‑29a in thermal skin tissues of mice and human hypertrophic scar fibroblasts (HSFBs) was detected via reverse transcription‑quantitative PCR. Exosomes derived from miR‑29a‑modified hADSCs were extracted and the influence of miR‑29a‑modified hADSCs‑exo on the proliferation and function of HSFBs was determined. Lastly, the effect of miR‑29a‑modified hADSCs‑exo on scar formation was determined using a thermal mouse model. The results demonstrated that miR‑29a was downregulated in scar tissues after scalding and in HSFBs. After treating HSFBs with miR‑29a‑modified hADSC exosomes, miR‑29a‑overexpressing hADSC exosomes inhibited the proliferation and migration of HSFBs. Moreover, it was found that TGF‑β2 was the target of miR‑29a, and that hADSC exosome‑derived miR‑29a inhibited the fibrosis of HSFBs and scar hyperplasia after scalding in mice by targeting the TGF‑β2/Smad3 signaling pathway. In summary, the current data indicated that miR‑29a‑modified hADSC exosome therapy can decrease scar formation by inhibiting the TGF‑β2/Smad3 signaling pathway via its derived exogenous miR‑29a, and this may be useful for the future treatment of pathological scars by providing a potential molecular basis.

摘要

病理性瘢痕主要包括增生性瘢痕和瘢痕疙瘩,其发病率较高。此外,这些瘢痕严重影响患者的外观,并伴有明显的疼痛。本研究旨在探讨人脂肪间充质干细胞(hADSCs)外泌体中的 microRNA(miR)-29a 对瘢痕形成的抑制作用。首先,通过逆转录定量 PCR 检测了 miR-29a 在小鼠热皮肤组织和人增生性瘢痕成纤维细胞(HSFBs)中的表达。提取了 miR-29a 修饰的 hADSCs 衍生的外泌体,并确定了 miR-29a 修饰的 hADSCs-Exo 对 HSFBs 增殖和功能的影响。最后,采用热鼠模型确定了 miR-29a 修饰的 hADSCs-Exo 对瘢痕形成的影响。结果表明,烫伤后瘢痕组织和 HSFBs 中 miR-29a 下调。用 miR-29a 修饰的 hADSC 外泌体处理 HSFBs 后,miR-29a 过表达的 hADSC 外泌体抑制了 HSFBs 的增殖和迁移。此外,研究发现 TGF-β2 是 miR-29a 的靶基因,hADSC 外泌体衍生的 miR-29a 通过靶向 TGF-β2/Smad3 信号通路抑制烫伤后 HSFBs 的纤维化和瘢痕增生。综上所述,该研究数据表明,miR-29a 修饰的 hADSC 外泌体治疗可通过其衍生的外源性 miR-29a 抑制 TGF-β2/Smad3 信号通路来减少瘢痕形成,这可能为病理性瘢痕的未来治疗提供一种潜在的分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/ae01cdb1c431/mmr-24-05-12398-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/dd143bdb8417/mmr-24-05-12398-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/6f4497109ac2/mmr-24-05-12398-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/06f0f5f4201d/mmr-24-05-12398-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/c604ffbe3427/mmr-24-05-12398-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/e880c16db482/mmr-24-05-12398-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/9c0ea683efad/mmr-24-05-12398-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/ae01cdb1c431/mmr-24-05-12398-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/dd143bdb8417/mmr-24-05-12398-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/6f4497109ac2/mmr-24-05-12398-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/06f0f5f4201d/mmr-24-05-12398-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/c604ffbe3427/mmr-24-05-12398-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/e880c16db482/mmr-24-05-12398-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/9c0ea683efad/mmr-24-05-12398-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8436211/ae01cdb1c431/mmr-24-05-12398-g06.jpg

相似文献

1
Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.miR-29a 修饰的脂肪间充质干细胞来源的外泌体通过抑制 TGF-β2/Smad3 信号通路减少过度瘢痕形成。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12398. Epub 2021 Sep 3.
2
Exosomal miR‑194 from adipose‑derived stem cells impedes hypertrophic scar formation through targeting TGF‑β1.脂肪来源干细胞外泌体 miR-194 通过靶向 TGF-β1 抑制增生性瘢痕形成。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13340. Epub 2024 Sep 27.
3
Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.骨髓间充质干细胞通过旁分泌信号传导抑制增生性瘢痕成纤维细胞和瘢痕疙瘩成纤维细胞的增殖和促纤维化表型。
J Dermatol Sci. 2016 Aug;83(2):95-105. doi: 10.1016/j.jdermsci.2016.03.003. Epub 2016 Mar 4.
4
MiR-141-3p-Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment.载 miR-141-3p 的功能性外泌体载入可溶解微针阵列治疗增生性瘢痕。
Small. 2024 Feb;20(8):e2305374. doi: 10.1002/smll.202305374. Epub 2023 Sep 18.
5
Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.人脂肪间充质干细胞来源的外泌体通过 miR-192-5p/IL-17RA/Smad 轴减轻增生性瘢痕纤维化。
Stem Cell Res Ther. 2021 Mar 31;12(1):221. doi: 10.1186/s13287-021-02290-0.
6
Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.人脂肪间充质干细胞来源的外泌体通过下调转化生长因子-β2 和 Notch-1 的表达抑制瘢痕疙瘩成纤维细胞细胞外基质的产生。
Bioengineered. 2022 Apr;13(4):8515-8525. doi: 10.1080/21655979.2022.2051838.
7
Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.针对 TGF-β/Smad 信号通路的当前潜在治疗策略,以减轻瘢痕疙瘩和增生性瘢痕的形成。
Biomed Pharmacother. 2020 Sep;129:110287. doi: 10.1016/j.biopha.2020.110287. Epub 2020 Jun 12.
8
Exosome from adipose-derived mesenchymal stem cells attenuates scar formation through microRNA-181a/SIRT1 axis.脂肪间充质干细胞来源的外泌体通过 microRNA-181a/SIRT1 轴减轻瘢痕形成。
Arch Biochem Biophys. 2023 Sep 15;746:109733. doi: 10.1016/j.abb.2023.109733. Epub 2023 Aug 29.
9
Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.脐带间充质干细胞来源的外泌体微小RNA在伤口愈合过程中通过抑制转化生长因子-β/SMAD2信号通路抑制肌成纤维细胞分化。
Stem Cells Transl Med. 2016 Oct;5(10):1425-1439. doi: 10.5966/sctm.2015-0367. Epub 2016 Jul 7.
10
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits collagen synthesis in human hypertrophic scar fibroblasts by targeting Smad3 via miR-145.过氧化物酶体增殖物激活受体γ(PPAR-γ)激动剂通过miR-145靶向Smad3抑制人增生性瘢痕成纤维细胞中的胶原蛋白合成。
Biochem Biophys Res Commun. 2015 Mar 27;459(1):49-53. doi: 10.1016/j.bbrc.2015.02.061. Epub 2015 Feb 20.

引用本文的文献

1
Therapeutic Potential of Stem Cell-Derived Exosomes in Skin Wound Healing.干细胞来源的外泌体在皮肤伤口愈合中的治疗潜力
Biomimetics (Basel). 2025 Aug 20;10(8):546. doi: 10.3390/biomimetics10080546.
2
Systematic review of extracellular vesicle-derived microRNAs involved in organ fibrosis: implications for arthrofibrosis therapy.参与器官纤维化的细胞外囊泡衍生微小RNA的系统评价:对关节纤维化治疗的意义
J Transl Med. 2025 Jul 17;23(1):802. doi: 10.1186/s12967-025-06810-x.
3
Platelet-rich plasma-derived exosomes stimulate hair follicle growth through activation of the Wnt/β-Catenin signaling pathway.

本文引用的文献

1
Exosomes Isolated From Bone Marrow Mesenchymal Stem Cells Exert a Protective Effect on Osteoarthritis via lncRNA LYRM4-AS1-GRPR-miR-6515-5p.从骨髓间充质干细胞中分离的外泌体通过lncRNA LYRM4-AS1-GRPR-miR-6515-5p对骨关节炎发挥保护作用。
Front Cell Dev Biol. 2021 May 28;9:644380. doi: 10.3389/fcell.2021.644380. eCollection 2021.
2
Mesenchymal stromal cell-derived extracellular vesicles for bone regeneration therapy.间充质基质细胞衍生的细胞外囊泡用于骨再生治疗。
Bone Rep. 2021 May 17;14:101093. doi: 10.1016/j.bonr.2021.101093. eCollection 2021 Jun.
3
miRNA in cardiac development and regeneration.
富含血小板血浆来源的外泌体通过激活Wnt/β-连环蛋白信号通路刺激毛囊生长。
Regen Ther. 2025 Apr 17;29:435-446. doi: 10.1016/j.reth.2025.04.003. eCollection 2025 Jun.
4
Adipose-Derived Stem Cell Products and Combination Therapies for the Treatment of Pathological Scars: A Review of Current Preclinical and Clinical Studies.脂肪源性干细胞产品及联合疗法治疗病理性瘢痕:当前临床前和临床研究综述
Clin Cosmet Investig Dermatol. 2025 May 27;18:1309-1337. doi: 10.2147/CCID.S511067. eCollection 2025.
5
From bench to bedside: the research status and application opportunity of extracellular vesicles and their engineering strategies in the treatment of skin defects.从 bench 到床边:细胞外囊泡及其工程策略在皮肤缺损治疗中的研究现状与应用机遇
J Nanobiotechnology. 2025 May 25;23(1):375. doi: 10.1186/s12951-025-03461-4.
6
Precision exosome engineering for enhanced wound healing and scar revision.用于促进伤口愈合和瘢痕修复的精准外泌体工程。
J Transl Med. 2025 May 23;23(1):578. doi: 10.1186/s12967-025-06578-0.
7
Exosomes as natural vectors for therapeutic delivery of bioactive compounds in skin diseases.外泌体作为治疗性递送生物活性化合物治疗皮肤疾病的天然载体。
Front Pharmacol. 2025 Apr 28;16:1485769. doi: 10.3389/fphar.2025.1485769. eCollection 2025.
8
Adipose-Derived Stem Cell Therapy in Hypertrophic and Keloid Scars: A Systematic Review of Experimental Studies.脂肪源性干细胞疗法治疗增生性瘢痕和瘢痕疙瘩:实验研究的系统评价
Plast Surg (Oakv). 2025 May;33(2):318-328. doi: 10.1177/22925503231195017. Epub 2023 Aug 21.
9
LncRNA PVT1 Promotes the Progress of Hypertrophic Scar via Regulating the Proliferation and Migration of Myofibroblasts Through Targeting miR-29a-3p/STAT3.长链非编码RNA PVT1通过靶向miR-29a-3p/STAT3调控肌成纤维细胞的增殖和迁移促进增生性瘢痕进展。
Clin Cosmet Investig Dermatol. 2025 Apr 15;18:907-917. doi: 10.2147/CCID.S510079. eCollection 2025.
10
MiR-29a-3p inhibits fibrosis of diabetic kidney disease in diabetic mice downregulation of DNA methyl transferase 3A and 3B.MiR-29a-3p通过下调DNA甲基转移酶3A和3B抑制糖尿病小鼠的糖尿病肾病纤维化。
World J Diabetes. 2025 Apr 15;16(4):93630. doi: 10.4239/wjd.v16.i4.93630.
心脏发育与再生中的微小RNA
Cell Regen. 2021 Jun 1;10(1):14. doi: 10.1186/s13619-021-00077-5.
4
Extracellular vesicles containing miR-146a-5p secreted by bone marrow mesenchymal cells activate hepatocytic progenitors in regenerating rat livers.骨髓间充质细胞分泌的含有 miR-146a-5p 的细胞外囊泡激活再生大鼠肝脏中的肝祖细胞。
Stem Cell Res Ther. 2021 May 29;12(1):312. doi: 10.1186/s13287-021-02387-6.
5
MiR-182 Promotes Ischemia/Reperfusion-Induced Acute Kidney Injury in Rat by Targeting FoxO3.miR-182 通过靶向 FoxO3 促进大鼠缺血/再灌注诱导的急性肾损伤。
Urol Int. 2021;105(7-8):687-696. doi: 10.1159/000515649. Epub 2021 May 7.
6
Adipose-derived stem cell induced-tissue repair or wound healing is mediated by the concomitant upregulation of miR-21 and miR-29b expression and activation of the AKT signaling pathway.脂肪源干细胞诱导的组织修复或伤口愈合是通过 miR-21 和 miR-29b 表达的同时上调以及 AKT 信号通路的激活来介导的。
Arch Biochem Biophys. 2021 Jul 15;705:108895. doi: 10.1016/j.abb.2021.108895. Epub 2021 Apr 30.
7
Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects.脂肪干细胞联合富血小板血浆促进全层皮肤缺损大鼠模型的伤口愈合。
Stem Cell Res Ther. 2021 Apr 6;12(1):226. doi: 10.1186/s13287-021-02257-1.
8
Therapeutic applications of adipose cell-free derivatives: a review.脂肪细胞无细胞衍生物的治疗应用:综述。
Stem Cell Res Ther. 2020 Jul 22;11(1):312. doi: 10.1186/s13287-020-01831-3.
9
Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.针对 TGF-β/Smad 信号通路的当前潜在治疗策略,以减轻瘢痕疙瘩和增生性瘢痕的形成。
Biomed Pharmacother. 2020 Sep;129:110287. doi: 10.1016/j.biopha.2020.110287. Epub 2020 Jun 12.
10
Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing.间充质干细胞衍生的细胞外囊泡在再生医学中的应用:在皮肤伤口愈合中的应用
Front Bioeng Biotechnol. 2020 Mar 3;8:146. doi: 10.3389/fbioe.2020.00146. eCollection 2020.